E-LIB Suche - Ergebnisse für: Bosch, Bronwyn

1

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://eprints.lse.ac.uk/120539/1/frph_05_1133556.pdf. , 2023

Link: http://eprints.lse.ac.uk..

2

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Comparing Prospective Incident Severe Acute Respiratory Syn..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757672/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Randomized clinical trial of nitazoxanide or sofosbuvir/dac..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384711/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Randomized clinical trial of nitazoxanide or sofosbuvir/dac..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://eprints.lse.ac.uk/117167/1/dkac266.pdf. , 2022

Link: http://eprints.lse.ac.uk..

6

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W D Francois ; Sokhela, Simiso ; Calmy, Alexandra...
info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0000000000003092. , 2021

Link: https://archive-ouverte...

7

Weight gain stopping/switch rules for antiretroviral clinic..:

VENTER, WD Francois ; SOKHELA, Simiso ; CALMY, Alexandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694575/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W.D. Francois ; Sokhela, Simiso ; Calmy, Alexandra...
info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0000000000003092. , 2021

Link: https://hal.umontpellier..

9

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W.D. Francois ; Sokhela, Simiso ; Calmy, Alexandra...
info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0000000000003092. , 2021

Link: https://hal.umontpellier..

10

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tamara Tovar Sanchez ; Mireille Mpoudi-Etame ; Charles Kouanfack...
https://www.frontiersin.org/articles/10.3389/frph.2023.1133556/full. , 2023

Link: https://doi.org/10.3389/..

11

Field-deployable viral diagnostics using CRISPR-Cas13:

Myhrvold, Cameron ; Freije, Catherine A ; Gootenberg, Jonathan S...
http://dx.doi.org/10.1126/science.aas8836. , 2019

Link: https://hdl.handle.net/1..

12

Field-deployable viral diagnostics using CRISPR-Cas13:

Myhrvold, Cameron ; Freije, Catherine A ; Gootenberg, Jonathan S...
Science. , 2018

Link: http://hdl.handle.net/11..

13

Zika virus evolution and spread in the Americas:

Metsky, Hayden C ; Matranga, Christian B ; Wohl, Shirlee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563848/. , 2017

Link: http://www.ncbi.nlm.nih...

14

Zika virus evolution and spread in the Americas:

Matranga, Christian B ; Wohl, Shirlee ; Freije, Catherine A...
http://dx.doi.org/doi:10.1038/nature22402. , 2017

Link: http://hdl.handle.net/17..

15

Potential Drug Abuse Therapeutics Derived from the Hallucin..:

Prevatt-Smith, Katherine M ; Lovell, Kimberly M ; Simpson, Denise S...
Prevatt-Smith, K. M., Lovell, K. M., Simpson, D. S., Day, V. W., Douglas, J. T., Bosch, P., … Prisinzano, T. E. (2011). Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A. MedChemComm, 2(12), 1217–1222. http://doi.org/10.1039/C1MD00192B. , 2017

Link: http://hdl.handle.net/18..